April 3, 2026
TOPLINE: Among parous women, an additional pregnancy was associated with an isolated decline in whole-body insulin sensitivity over 10 years, with no corresponding changes in the […]
April 3, 2026
The use of SGLT2 inhibitors in people with type 2 diabetes (T2D) who also have liver cirrhosis led to reductions in the risks for end-stage kidney […]
April 2, 2026
TOPLINE: Patients with colorectal cancer (CRC) who had diabetes — particularly those with both microvascular and macrovascular complications — were far less likely to undergo major […]
April 2, 2026
Radioactive iodine (RAI) treatment for hyperthyroidism was associated with an increased incidence of breast cancer but not with an overall increase in cancer incidence or mortality, […]
April 2, 2026
A group of diabetes professionals is proposing a change from the term prediabetes to the use of a three-stage classification of type 2 diabetes (T2D), with […]
April 1, 2026
The first-ever clinical trial of an adeno-associated virus (AAV) gene therapy for type 1 diabetes (T1D) is set to begin this year. The PROGRESS study will […]
April 1, 2026
An overnight fasting regimen commencing at least 3 hours prior to bedtime led to significant improvements in key cardiometabolic measures including nighttime blood pressure, heart rate […]
March 31, 2026
TOPLINE: In patients with partial lipodystrophy (PLD), treatment with tirzepatide — a dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist — was associated with significant reductions in body […]
March 31, 2026
TOPLINE: In adults with type 2 diabetes (T2D) who did not achieve glycemic control while on dulaglutide, switching to tirzepatide produced greater improvements in emotional health […]